Dr. Mark Warne


Insights generated from structured data and analysis using Artificial Intelligence and Machine Learning technologies will transform the way in which pharma and biotech operate in the future. I see this as a common theme running through my role as a non-executive Director at Genomics plc, as Chief Executive at DeepMatter Group plc and my the ten years I spent investing in Healthcare at IP Group plc.

Every experience involves learning something new, so I don’t think I can pinpoint the proudest moment in my career yet.

I’m a massive advocate of high growth data-centric businesses in life science and I am looking forward to Genomics ‘winning’ in this fast emerging and industry changing space.

Outside of work I enjoy sailing, scuba diving, running, cycling, eating and drinking.